Day 4 Program

Poster Spotlight 9: This is Not Your Halsted’s Mastectomy: Balancing Innovation and Outcomes

Day 4: December 11, 2026

7:00 AM–8:30 AM CST

221 ABC

Session Details

Moderator

E Shelley Hwang

PS9-1

Comparison of Oncologic and Surgical Outcomes Between Robotic Mastectomy and Conventional Mastectomy Followed by Reconstruction After Neoadjuvant Chemotherapy in Breast Cancer Patients

Joongkwon Lee, Asan Medical Center, Seoul, Korea, Republic of

PS9-2

Impact of skin and nipple-areolar complex preservation on local recurrence after mastectomy: A competing-risk analysis

Eunhye Kang, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of

PS9-3

Therapeutic Nipple-Sparing Mastectomy with Immediate Breast Reconstruction: Results of the Multicenter Prospective MAPAM-01 Trial (NCT02311959)

Eva Jouve, University of Toulouse – Claudius Regaud Institute – IUCT Oncopole, TOULOUSE, France

PS9-4

Longitudinal changes in patient-reported outcomes following skin- or nipple-sparing mastectomy and pre-pectoral versus sub-pectoral implant positioning – a secondary endpoint analysis of the OPBC-02/PREPEC trial

Martin Heidinger, University Hospital Basel, Basel, Switzerland

PS9-5

Exploring women’s experiences of seeking and professionals’ perspectives on offering contralateral symmetrising mastectomy as an alternative to breast reconstruction after unilateral mastectomy for breast cancer: A UK Qualitative Interview Study

Shelley Potter, Bristol Medical School, Bristol, United Kingdom

PS9-7

Use of adjunct mesh in pre-pectoral implant-based breast reconstruction and surgical risk in the setting of radiotherapy

Martin Heidinger, University Hospital Basel, Basel, Switzerland

PS9-8

Surgical complications by pre- versus subpectoral implant-based breast reconstruction: A preplanned OPBC-02/PREPEC sub-study

Martin Heidinger, University Hospital Basel, Basel, Switzerland

PS9-9

Partbrecon-pro study: PARTial BREast reCONstruction with chest wall perforator flap, a PROspective study of clinical and patient reported outcomes: early results

Amit Agrawal, Cambridge University Hospitals, Cambridge, United Kingdom

PS9-10

Profunda versus Lumbar Artery Perforator Flaps in Autologous Breast Reconstruction: Outcomes in 795 Flaps

Dominic Henn, UT Southwestern, Dallas, TX

PS9-11

Early Postoperative Pain Reduction and Opioid-sparing Effect of Suzetrigine in Autologous Breast Reconstruction

Dominic Henn, UT Southwestern Medical Center, Dallas, TX

PS9-12

Innovating Reconstruction Approaches

Marios Konstantinos Tasoulis, The Royal Marsden Hospital, London, United Kingdom